At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

Learn More
The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.
Learn More
Hatteras’ mission is to create transformative healthcare companies in the research-driven, undercapitalized regions of the Southeast and Mid-Atlantic. Over half of our portfolio companies were created with our initial investment.
Learn More

Portfolio

Latest News

Clearside Biomedical, Inc. Announces Ongoing Results in Phase 1/2 Clinical Trial in Patients with Non-infectious Uveitis

October 15, 2014

Alpharetta, Ga.–(BUSINESS WIRE)–Clearside Biomedical, Inc. today announced the eight-week ongoing observations in patients with non-infectious uveitis. In the phase 1/2 clinical study, eight patients diagnosed with non-infectious uveitis at three…

More News